Total Payments
$1,769
2024 Payments
$360.26
Companies
12
Transactions
66
Medicare Patients
8,429
Medicare Billing
$471,159
Payment Breakdown by Category
Food & Beverage$1,599 (90.4%)
Education$169.94 (9.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,599 | 64 | 90.4% |
| Education | $169.94 | 2 | 9.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $553.91 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $531.61 | 18 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $126.59 | 1 | $0 (2021) |
| GENZYME CORPORATION | $111.47 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $109.99 | 1 | $0 (2023) |
| UCB, Inc. | $106.78 | 3 | $0 (2024) |
| Amgen Inc. | $92.61 | 1 | $0 (2024) |
| Incyte Corporation | $54.40 | 1 | $0 (2021) |
| Kerecis Limited | $25.46 | 1 | $0 (2024) |
| Lilly USA, LLC | $22.50 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.26 | 10 | ABBVIE INC. ($132.69) |
| 2023 | $631.91 | 23 | ABBVIE INC. ($226.70) |
| 2022 | $92.08 | 5 | Lilly USA, LLC ($22.50) |
| 2021 | $684.76 | 28 | Janssen Biotech, Inc. ($259.10) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $43.06 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $92.61 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $94.86 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $25.46 | General |
| Category: Wound Care | ||||||
| 04/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $66.44 | General |
| Category: Immunology | ||||||
| 01/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $109.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: Immunology | ||||||
| 11/28/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $115.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $99.64 | General |
| Category: Immunology | ||||||
| 09/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $89.15 | General |
| Category: Immunology | ||||||
| 07/27/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/06/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 05/23/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,751 | 3,868 | $602,844 | $166,416 |
| 2022 | 16 | 2,345 | 3,313 | $487,118 | $137,200 |
| 2021 | 11 | 1,559 | 2,295 | $225,012 | $81,783 |
| 2020 | 12 | 1,774 | 2,541 | $278,151 | $85,760 |
Total Patients
8,429
Total Services
12,017
Medicare Billing
$471,159
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 700 | 807 | $148,488 | $40,840 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 447 | 526 | $136,760 | $39,155 | 28.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 437 | 527 | $121,210 | $34,010 | 28.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 387 | 465 | $62,310 | $15,453 | 24.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 114 | 123 | $26,076 | $6,680 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $20,220 | $5,212 | 25.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 138 | 147 | $16,611 | $5,006 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $19,800 | $4,446 | 22.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 239 | 958 | $12,454 | $4,136 | 33.2% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 33 | 48 | $12,960 | $4,097 | 31.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 26 | 28 | $10,164 | $3,012 | 29.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 19 | $5,035 | $1,465 | 29.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $4,200 | $1,228 | 29.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $2,058 | $575.88 | 28.0% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 16 | 16 | $2,912 | $561.77 | 19.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 13 | $1,391 | $413.16 | 29.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 15 | $195.00 | $126.00 | 64.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 578 | 634 | $116,656 | $33,823 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 329 | 383 | $99,580 | $28,877 | 29.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 348 | 408 | $93,840 | $27,189 | 29.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 358 | 422 | $56,548 | $14,140 | 25.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 126 | 139 | $29,468 | $7,831 | 26.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 124 | 125 | $14,125 | $4,311 | 30.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 85 | 85 | $19,125 | $4,200 | 22.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 224 | 936 | $12,168 | $4,152 | 34.1% |
About Rachel Talbot, DNP
Rachel Talbot, DNP is a Family healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1972961472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Talbot, DNP has received a total of $1,769 in payments from pharmaceutical and medical device companies, with $360.26 received in 2024. These payments were reported across 66 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,599).
As a Medicare-enrolled provider, Talbot has provided services to 8,429 Medicare beneficiaries, totaling 12,017 services with total Medicare billing of $471,159. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Charlottesville, VA
- Active Since 01/29/2016
- Last Updated 08/08/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972961472
Products in Payments
- TREMFYA (Drug) $531.61
- SKYRIZI (Biological) $459.05
- DUOBRII (Drug) $126.59
- SPEVIGO (Drug) $109.99
- RINVOQ (Biological) $94.86
- Otezla (Drug) $92.61
- DUPIXENT (Biological) $89.15
- Cimzia (Drug) $63.72
- OPZELURA (Drug) $54.40
- Bimzelx (Biological) $43.06
- LIBTAYO (Biological) $41.59
- Kerecis Omega3 SurgiClose (Device) $25.46
- OLUMIANT (Drug) $22.50
- BLU-U (Medical Supply) $14.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Charlottesville
Ellen Wermter, Np, NP
Family — Payments: $209,331
Family $209,331
Amy Beyer, Fnp-C, FNP-C
Family — Payments: $5,859
Family $5,859
Heather Camp, Fnp, FNP
Family — Payments: $3,322
Family $3,322
Adam Navone
Family — Payments: $2,330
Family $2,330
Jessica Denomme, Fnp, FNP
Family — Payments: $1,444
Family $1,444
Mrs. Lorraine Rilko, Fnp, FNP
Family — Payments: $1,383
Family $1,383